NTHI:NASDAQ, NeOnc Technologies Holdings, Inc.

Why NTHI stock fell on November 19

NeOnc Technologies Holdings, Inc. fell 16.3% on Thursday, November 19, 2026, on 387,500 shares, 2.1 times its average daily volume. The headline around the move:

NTHI stock overview

NeOnc Technologies Holdings, Inc. (NTHI:NASDAQ) closed at $3.15 on November 20, 2026, down 9.48% on the day. The stock trades 72.3% below its 52-week high of $11.38 and 25.9% above its 52-week low of $2.50. Over the past year, it lost 57.0%. NeOnc Technologies Holdings, Inc. is part of the Health Care sector.

Key figures

Price
$3.15
Day change
-9.48%
Volume
225,113
Average volume
186,331
Market cap
90M+
52-week range
$2.50 – $11.38
50-day average
$3.30
200-day average
$5.11

Price action over the past year

In 252 trading sessions since November 20, 2025, NTHI closed higher on 117 days (46%). Its best day was August 14, 2026 (+31.46%) and its worst was August 12, 2026 (-20.46%). The stock moved 10% or more in a single session 28 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

NTHI news

About NeOnc Technologies Holdings, Inc.

Our company (f/k/a NAS-ONC, Inc.) was formed in 2008, devoted to developing new drugs with new delivery modes. As a clinical-stage biopharmaceutical company, we have focused on establishing treatments for intracranial malignancies, i.e., aggressive cancers located in the brain. These cancer types include primary brain cancers, such as glioblastoma, and secondary brain cancers, that have arrived through metastatic spread from other cancers throughout the body, such as melanoma or breast and lung cancer.

Similar stocks

Find more stocks like NTHI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.